A recent study has identified new biochemistry for RNA functions at low temperatures. Ribonucleic acid (RNA) is a vital ...

Exicure, Inc. ("Exicure" or the "Company") (Nasdaq: XCUR), announced today that on September 17, 2024, the Company received notice that the Nasdaq Hearings Panel ("Panel") granted an extension to ...

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful ...

Modified nucleotides like m5C in saRNA enhance vaccine efficacy, stability, and reduce inflammation, offering a promising ...

The market has climbed 1.0% in the last 7 days and is up 28% over the past 12 months, with earnings forecast to grow by 15% annually. In this dynamic environment, identifying high-growth tech stocks ...

Moderna Inc. (NASDAQ: MRNA) made headlines during the pandemic for its messenger ribonucleic acid (mRNA) technology used in ...

Today engineers are putting their own spin on DNA computing, to both record data and serve as biological computers, yet until ...

Review highlights the growing evidence that aging is linked to reduced expression of long genes, offering insights into ...

Kenya has allowed GMOs in its territory although a court case stands in the way of implementation of the policy.

We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at ...

Analysts have recently evaluated Editas Medicine and provided 12-month price targets. The average target is $11.75, ...